Cargando…

Health and economic effects of introducing single-dose or two-dose human papillomavirus vaccination in India

BACKGROUND: Cervical cancer is a major public health problem in India, where access to prevention programmes is low. The WHO-Strategic Advisory Group of Experts recently updated their recommendation for human papillomavirus (HPV) vaccination to include a single-dose option in addition to the two-dos...

Descripción completa

Detalles Bibliográficos
Autores principales:	M de Carvalho, Tiago, Man, Irene, Georges, Damien, Saraswati, Lopamudra Ray, Bhandari, Prince, Kataria, Ishu, Siddiqui, Mariam, Muwonge, Richard, Lucas, Eric, Sankaranarayanan, Rengaswamy, Basu, Partha, Berkhof, Johannes, Bogaards, Johannes A, Baussano, Iacopo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632817/ https://www.ncbi.nlm.nih.gov/pubmed/37931940 http://dx.doi.org/10.1136/bmjgh-2023-012580

Ejemplares similares

Evidence-based impact projections of single-dose human papillomavirus vaccination in India: a modelling study
por: Man, Irene, et al.
Publicado: (2022)

Building resilient cervical cancer prevention through gender-neutral HPV vaccination
por: Man, Irene, et al.
Publicado: (2023)

Awareness, perceptions, and choices of physicians pertaining to human papillomavirus (HPV) vaccination in India: A formative research study
por: Kataria, Ishu, et al.
Publicado: (2022)

Current global status & impact of human papillomavirus vaccination: Implications for India
por: Sankaranarayanan, Rengaswamy, et al.
Publicado: (2016)

Prevention is life- and cost-saving
por: Baussano, Iacopo, et al.
Publicado: (2020)

Vaccine Effectiveness Following Routine Immunization With Bivalent Human Papillomavirus (HPV) Vaccine: Protection Against Incident Genital HPV Infections From a Reduced-Dosing Schedule
por: Hoes, Joske, et al.
Publicado: (2021)

Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesis
por: Bogaards, Johannes A, et al.
Publicado: (2015)

Sex-Specific Immunization for Sexually Transmitted Infections Such as Human Papillomavirus: Insights from Mathematical Models
por: Bogaards, Johannes A., et al.
Publicado: (2011)

A Bivariate Mixture Model for Natural Antibody Levels to Human Papillomavirus Types 16 and 18: Baseline Estimates for Monitoring the Herd Effects of Immunization
por: Vink, Margaretha A., et al.
Publicado: (2016)

Breast Cancer Screening Program in Morocco: Status of implementation, organization and performance
por: Basu, Partha, et al.
Publicado: (2018)

Pricing of HPV vaccines in European tender-based settings
por: Qendri, Venetia, et al.
Publicado: (2018)

Who Will Benefit From Expanding HPV Vaccination Programs to Boys?
por: Qendri, Venetia, et al.
Publicado: (2018)

Estimating the direct effect of human papillomavirus vaccination on the lifetime risk of screen‐detected cervical precancer
por: Inturrisi, Federica, et al.
Publicado: (2020)

Women with a positive high-risk human papillomavirus (HPV) test remain at increased risk of HPV infection and cervical precancer ≥15 years later
por: Inturrisi, Federica, et al.
Publicado: (2022)

Early effect of bivalent human papillomavirus vaccination on cytology outcomes in cervical samples among young women in the Netherlands
por: Schurink‐van ’t Klooster, Tessa M., et al.
Publicado: (2023)

A pilot study to evaluate home-based screening for the common non-communicable diseases by a dedicated cadre of community health workers in a rural setting in India
por: Basu, Partha, et al.
Publicado: (2019)

Options for design of real-world impact studies of single-dose vaccine schedules
por: Franceschi, Silvia, et al.
Publicado: (2018)

A systematic review of the evidence on peer education programmes for promoting the sexual and reproductive health of young people in India
por: Siddiqui, Mariam, et al.
Publicado: (2020)

Study of Knowledge, Attitudes, and Practices Toward Risk Factors and Early Detection of Noncommunicable Diseases Among Rural Women in India
por: Mahajan, Manoj, et al.
Publicado: (2019)

Human Papillomavirus Vaccination at a Time of Changing Sexual Behavior
por: Baussano, Iacopo, et al.
Publicado: (2016)

Are two doses of human papillomavirus vaccine sufficient for girls aged 15–18 years? Results from a cohort study in India
por: Bhatla, Neerja, et al.
Publicado: (2018)

Impacts of human papillomavirus vaccination for different populations: A modeling study
por: Baussano, Iacopo, et al.
Publicado: (2018)

Human Papillomavirus Genotype Replacement: Still Too Early to Tell?
por: Man, Irene, et al.
Publicado: (2020)

Mobile Screening Unit (MSU) for the Implementation of the ‘Screen and Treat’ Programme for Cervical Cancer Prevention In Pune, India
por: Joshi, Smita, et al.
Publicado: (2021)

Effectiveness of triennial screening with clinical breast examination: 14‐years follow‐up outcomes of randomized clinical trial in Trivandrum, India
por: Ramadas, Kunnambath, et al.
Publicado: (2022)

Vaccinating Women Previously Exposed to Human Papillomavirus: A Cost-Effectiveness Analysis of the Bivalent Vaccine
por: Turner, Hugo C., et al.
Publicado: (2013)

Two-dose recommendation for Human Papillomavirus vaccine can be extended up to 18 years – updated evidence from Indian follow-up cohort study
por: Basu, Partha, et al.
Publicado: (2019)

Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study
por: Basu, Partha, et al.
Publicado: (2021)

Cancer Screening in the Coronavirus Pandemic Era: Adjusting to a New Situation
por: Basu, Partha, et al.
Publicado: (2021)

Correlation of Cervical Cancer Mortality with Fertility, Access to Health Care and Socioeconomic Indicators
por: Vale, Diama Bhadra, et al.
Publicado: (2019)

Upscaling human papillomavirus vaccination in high-income countries: impact assessment based on transmission model
por: Baussano, Iacopo, et al.
Publicado: (2014)

Population Impact of Girls-Only Human Papillomavirus 16/18 Vaccination in The Netherlands: Cross-Protective and Second-Order Herd Effects
por: Hoes, Joske, et al.
Publicado: (2020)

Evolution of patterns of care for women with cervical cancer in Morocco over a decade
por: Benider, Abdellatif, et al.
Publicado: (2022)

Agreement between Self- and PhysicianSampling for Detection of HighRisk Human Papillomavirus Infections in Women Attending Cervical Screening at National Cancer Institute, Thailand
por: Sangrajrang, Suleeporn, et al.
Publicado: (2023)

Magnivisualizer in the early detection of cervical neoplasia
por: Sankaranarayanan, Rengaswamy
Publicado: (2014)

A research agenda for non-communicable disease prevention and control in India
por: Kataria, Ishu, et al.
Publicado: (2020)

Comparative accuracy of Pap smear and HPV screening in Ubon Ratchathani in Thailand
por: Sangrajrang, Suleeporn, et al.
Publicado: (2016)

Peak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6/16/18/31/33/45/52/58 induced by bivalent and quadrivalent HPV vaccines
por: Mariz, Filipe Colaço, et al.
Publicado: (2020)

Human papillomavirus vaccine coverage in Rwanda: A population-level analysis by birth cohort
por: Sayinzoga, Felix, et al.
Publicado: (2020)

Errors introduced by dose scaling for relative dosimetry
por: Watanabe, Yoichi, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_c0m6a5mcvsn2m5revh8cvt2uir